Src family tyrosine kinases are activated by Flt3 and are involved in the proliferative effects of leukemia-associated Flt3 mutations.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Experimental Hematology

• Publication date

  2005-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.EXPHEM.2005.01.004PMID 15781338
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adoptive Immunotherapy for EBV-associated Malignancies

  2005cited by this paper
• FLT3 mutations in childhood acute lymphoblastic leukemia.

  2004cited by this paper
• Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AML.

  2004cited by this paper
• The medical management of pancreatic cancer: a review.

  2003cited by this paper
• FLT3: ITDoes matter in leukemia

  2003cited by this paper
• FLT3 mutations in acute myeloid leukemia cell lines

  2003cited by this paper
• BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571.

  2003cited by this paper
• Flt3 mutations and leukaemia

  2003cited by this paper
• FLT3 and its Role in the Pathogenesis of Acute Myeloid Leukaemia

  2003cited by this paper
• The role of FLT3 in haematopoietic malignancies

  2003cited by this paper
• Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr–Abl signal transduction and oncogenesis

  2002cited by this paper
• JAKs, STATs and Src kinases in hematopoiesis

  2002cited by this paper
• PML/RARα and FLT3-ITD induce an APL-like disease in a mouse model

  2002cited by this paper
• FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model.

  2002cited by this paper
• The roles of FLT3 in hematopoiesis and leukemia.

  2002cited by this paper
• PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model.

  2002cited by this paper
• Analysing c-kit internalization using a functional c-kit-EGFP chimera containing the fluorochrome within the extracellular domain

  2002cited by this paper
• Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies.

  2001cited by this paper
• A FLT3 tyrosine kinase inhibitor is selectively cytotoxic to acute myeloid leukemia blasts harboring FLT3 internal tandem duplication mutations.

  2001cited by this paper
• In vitro tumor-pulsed or in vivo Flt3 ligand-generated dendritic cells provide protection against acute myelogenous leukemia in nontransplanted or syngeneic bone marrow-transplanted mice.

  2001cited by this paper
• Lyn is required for normal stem cell factor-induced proliferation and chemotaxis of primary hematopoietic cells.

  2001cited by this paper
• Role of hematopoietic growth factors/flt3 ligand in expansion and regulation of dendritic cells

  2001cited by this paper
• Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines

  2000cited by this paper
• Antileukemic activity of Flt3 ligand in murine leukemia.

  2000cited by this paper
• Src Family Kinases Negatively Regulate Platelet-derived Growth Factor α Receptor-dependent Signaling and Disease Progression*

  2000cited by this paper
• Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cells

  2000cited by this paper
• Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways.

  2000cited by this paper
• Defective Internalization and Sustained Activation of Truncated Granulocyte Colony-Stimulating Factor Receptor Found in Severe Congenital Neutropenia/Acute Myeloid Leukemia

  1999cited by this paper
• Signaling via Src family kinases is required for normal internalization of the receptor c-Kit.

  1999cited by this paper
• Src-related protein tyrosine kinases in hematopoiesis.

  1999cited by this paper
• ErbB Receptor-induced Activation of Stat Transcription Factors Is Mediated by Src Tyrosine Kinases*

  1999cited by this paper
• p85 subunit of PI3 kinase does not bind to human Flt3 receptor, but associates with SHP2, SHIP, and a tyrosine-phosphorylated 100-kDa protein in Flt3 ligand-stimulated hematopoietic cells.

  1999cited by this paper
• Deletion of a critical internalization domain in the G-CSFR in acute myelogenous leukemia preceded by severe congenital neutropenia.

  1999cited by this paper
• Defective internalization and sustained activation of truncated granulocyte colony-stimulating factor receptor found in severe congenital neutropenia/acute myeloid leukemia.

  1999cited by this paper
• Therapeutic targeting of Src-kinase Lyn in myeloid leukemic cell growth

  1999cited by this paper
• Kit signaling through PI 3‐kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation

  1998cited by this paper
• Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product

  1998cited by this paper
• Positive and negative roles of the tyrosine kinase Lyn in B cell function.

  1998cited by this paper
• c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities.

  1998cited by this paper
• Lyn Associates with the Juxtamembrane Region of c-Kit and Is Activated by Stem Cell Factor in Hematopoietic Cell Lines and Normal Progenitor Cells*

  1997cited by this paper
• Bryostatin 1 (bryo1)-induced monocytic differentiation in THP-1 human leukemia cells is associated with enhanced c-fyn tyrosine kinase and M-CSF receptors.

  1997cited by this paper
• Involvement of Proteasomes in Regulating Jak-STAT Pathways upon Interleukin-2 Stimulation*

  1997cited by this paper
• Internal tandem duplication of the flt3 gene found in acute myeloid leukemia.

  1996cited by this paper
• Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor

  1996cited by this paper
• Substrate specificities and identification of a putative binding site for PI3K in the carboxy tail of the murine Flt3 receptor tyrosine kinase.

  1994cited by this paper
• STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells.

  1994cited by this paper
• Mitogenic signalling and substrate specificity of the Flk2/Flt3 receptor tyrosine kinase in fibroblasts and interleukin 3-dependent hematopoietic cells

  1993cited by this paper
• Characterization of the protein encoded by the flt3 (flk2) receptor-like tyrosine kinase gene.

  1993cited by this paper
• Interleukin-3 regulates the activity of the LYN protein-tyrosine kinase in myeloid-committed leukemic cell lines.

  1992cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• The Inositol-5-Phosphatase SHIP1: Expression, Regulation and Role in Acute Lymphoblastic Leukemia

  2025cites this paper
• Priming lymphocyte responsiveness and differential T cell signaling in pediatric IBD patients with Cannabis use

  2024cites this paper
• Somatic Mutation Profile as a Predictor of Treatment Response and Survival in Unresectable Pancreatic Ductal Adenocarcinoma Treated with FOLFIRINOX and Gemcitabine Nab-Paclitaxel

  2024cites this paper
• The dualistic role of Lyn tyrosine kinase in immune cell signaling: implications for systemic lupus erythematosus

  2024cites this paper
• Activated Src kinases downstream of BCR-ABL and Flt3 induces proteasomal degradation of SHIP1 by phosphorylation of tyrosine 1021.

  2023cites this paper
• Proteomic and phosphoproteomic landscapes of acute myeloid leukemia

  2022cites this paper
• Mining of transcriptome identifies CD109 and LRP12 as possible biomarkers and deregulation mechanism of T cell receptor pathway in Acute Myeloid Leukemia

  2022cites this paper
• The IL-3, IL-5, and GM-CSF common receptor beta chain mediates oncogenic activity of FLT3-ITD-positive AML

  2021cites this paper
• Leukemia Stem Cell Release From the Stem Cell Niche to Treat Acute Myeloid Leukemia

  2020cites this paper
• SRC-Family Kinases in Acute Myeloid Leukaemia and Mastocytosis

  2020influential citation
• FMS-like Tyrosine Kinase 3/FLT3: From Basic Science to Clinical Implications.

  2019cites this paper
• The role of SRC family kinases in FLT3 signaling.

  2019cites this paper
• Discovery of Non-peptide Small Molecule Allosteric Modulators of the Src-family Kinase, Hck

  2019cites this paper
• Targeting Tyrosine Kinases in Acute Myeloid Leukemia: Why, Who and How?

  2019cites this paper
• Amino alkynylisoquinoline and alkynylnaphthyridine compounds potently inhibit acute myeloid leukemia proliferation in mice

  2019cites this paper
• Selective Inhibition of the Myeloid Src-Family Kinase Fgr Potently Suppresses AML Cell Growth in Vitro and in Vivo.

  2018cites this paper
• Comparison of the Kinase Profile of Midostaurin (Rydapt) with That of Its Predominant Metabolites and the Potential Relevance of Some Newly Identified Targets to Leukemia Therapy.

  2018cites this paper
• The Src family kinase Fgr is a transforming oncoprotein that functions independently of SH3-SH2 domain regulation

  2018cites this paper
• Translational studies on acute myeloid leukemia focus on the receptor tyrosine kinase FLT3

  2018cites this paper
• The Src family kinase LCK cooperates with oncogenic FLT3/ITD in cellular transformation

  2017cites this paper
• FLT3 and FLT3-ITD phosphorylate and inactivate the cyclin-dependent kinase inhibitor p27Kip1 in acute myeloid leukemia

  2017cites this paper
• differentiation therapy of myeloid leukemia reversing maturation arrest

  2017cites this paper
• Activity cliff for 7-substituted pyrrolo-pyrimidine inhibitors of HCK explained in terms of predicted basicity of the amine nitrogen.

  2017cites this paper
• Peripheral FLT-3 ligand levels as a pathobiological parameter duringthe clinical course of acute myeloid leukemia.

  2016cites this paper
• SIMULTANEOUS INHIBITION OF DRIVER AND EFFECTOR KINASES PROMOTES POTENT GROWTH ARREST OF AML CELLS IN VITRO AND IN VIVO

  2016cites this paper
• FYN expression potentiates FLT3-ITD induced STAT5 signaling in acute myeloid leukemia

  2016cites this paper
• Src family kinases and their role in hematological malignancies

  2015cites this paper
• Signal transduction in Acute Myeloid Leukemia - Implications for Novel Therapeutic Concepts.

  2015cites this paper
• Functional characterization of non-receptor tyrosine kinase dependent signal transduction in acute lymphoblastic leukemia of childhood

  2014cites this paper
• A Scalable Method for Molecular Network Reconstruction Identifies Properties of Targets and Mutations in Acute Myeloid Leukemia

  2014cites this paper
• Dasatinib Targets B-Lineage Cells but Does Not Provide an Effective Therapy for Myeloproliferative Disease in c-Cbl RING Finger Mutant Mice

  2014cites this paper
• Functions of Novel Ligand-independent Flt3 Alleles and RANKL in Promoting Dissemination of Murine B-Cell Leukemias to the Central Nervous System

  2014cites this paper
• SAR103168: a tyrosine kinase inhibitor with therapeutic potential in myeloid leukemias

  2013cites this paper
• Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia

  2013cites this paper
• A Pyrrolo-Pyrimidine Derivative Targets Human Primary AML Stem Cells in Vivo

  2013cites this paper
• Using combination therapy to override stromal-mediated chemoresistance in mutant FLT3-positive AML: synergism between FLT3 inhibitors, dasatinib/multi-targeted inhibitors and JAK inhibitors

  2012cites this paper
• The Protein Tyrosine Phosphatase, Shp2, Positively Contributes to FLT3-ITD-Induced Hematopoietic Progenitor Hyperproliferation and Malignant Disease In Vivo

  2012cites this paper
• SRC a critical signaling mediator in FLT 3 ITD positive AML

  2012cites this paper
• Src Inhibitors, PP2 and Dasatinib, Increase Retinoic Acid-Induced Association of Lyn and c-Raf (S259) and Enhance MAPK Dependent Differentiation of Myeloid Leukemia Cells

  2011cites this paper
• Histone deacetylase inhibitors regulate the proteasomal degradation of oncoproteins

  2011cites this paper
• Survey of Activated FLT3 Signaling in Leukemia

  2011cites this paper
• Survey of Activated FLT3 Signaling in Leukemia Please share how this access benefits you. Your story matters

  2011cites this paper
• Survey of Activated FLT 3 Signaling in Leukemia

  2011cites this paper
• c-Cbl and Cbl-b Ligases Mediate 17-Allylaminodemethoxygeldanamycin-induced Degradation of Autophosphorylated Flt3 Kinase with Internal Tandem Duplication through the Ubiquitin Proteasome Pathway*

  2011cites this paper
• PTPIP51 is phosphorylated by Lyn and c-Src kinases lacking dephosphorylation by PTP1B in acute myeloid leukemia.

  2011cites this paper
• MOLECULAR ADAPTATION TO ANTI-CANCER CHEMOTHERAPY IN LEUKEMIA

  2011cites this paper
• Ubiquitin conjugase UBCH8 targets active FMS-like tyrosine kinase 3 for proteasomal degradation

  2010cites this paper
• FES kinases are required for oncogenic FLT3 signaling

  2010cites this paper
• Dasatinib impairs long-term expansion of leukemic progenitors in a subset of acute myeloid leukemia cases

  2010cites this paper
• Crosstalks between the receptors tyrosine kinase EGFR and TrkA and the GPCR, FPR, in human monocytes are essential for receptors-mediated cell activation.

  2010cites this paper
• Dasatinib Inhibits the Growth of Molecularly Heterogeneous Myeloid Leukemias

  2010influential citation
• Connexin-based signaling in acute myelogenous leukemia (AML).

  2010cites this paper
• Oncogenic signaling from the hematopoietic growth factor receptors c-Kit and Flt3.

  2009cites this paper
• Age-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemia.

  2009cites this paper
• Ligand-induced Flt3-downregulation modulates cell death associated proteins and enhances chemosensitivity to idarubicin in THP-1 acute myeloid leukemia cells.

  2009cites this paper
• Activated Ca2+/calmodulin-dependent protein kinase IIgamma is a critical regulator of myeloid leukemia cell proliferation.

  2008cites this paper
• Deficiency of Src family kinases compromises the repopulating ability of hematopoietic stem cells.

  2008cites this paper
• Small molecules ATP-competitive inhibitors of FLT3: a chemical overview.

  2008cites this paper
• A critical role for Lyn in acute myeloid leukemia.

  2008cites this paper
• Src family kinases and the MEK/ERK pathway in the regulation of myeloid differentiation and myeloid leukemogenesis.

  2008cites this paper
• G-CSF stimulates Jak2-dependent Gab2 phosphorylation leading to Erk1/2 activation and cell proliferation.

  2008cites this paper
• FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications.

  2008cites this paper
• A celecoxib derivative inhibits focal adhesion signaling and induces caspase‐8‐dependent apoptosis in human acute myeloid leukemia cells

  2008cites this paper
• SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapy.

  2007cites this paper
• Src family tyrosine kinases phosphorylate Flt3 on juxtamembrane tyrosines and interfere with receptor maturation in a kinase-dependent manner

  2007cites this paper
• Src family tyrosine kinases phosphorylate Flt3 on juxtamembrane tyrosines and interfere with receptor maturation in a kinase-dependent manner

  2007cites this paper
• Procédé d'identification de médicaments candidats pour le traitement de la leucémie myéloïde aiguë

  2007cites this paper
• Leukemia

  2007cites this paper
• Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.

  2007cites this paper
• Chicken sarcoma to human cancers: a lesson in molecular therapeutics.

  2007cites this paper
• Lyn is an important component of the signal transduction pathway specific to FLT3/ITD and can be a therapeutic target in the treatment of AML with FLT3/ITD

  2007cites this paper
• Potential gene therapy strategies for cancer stem cells.

  2006cites this paper
• The duplicitous nature of the Lyn tyrosine kinase in growth factor signaling

  2006cites this paper
• Emerging Flt3 kinase inhibitors in the treatment of leukaemia

  2006cites this paper
• Identification of Y589 and Y599 in the juxtamembrane domain of Flt3 as ligand-induced autophosphorylation sites involved in binding of Src family kinases and the protein tyrosine phosphatase SHP2.

  2006cites this paper
• Cancer Stem Cells and Differentiation Therapy

  2006cites this paper
• Establishment of a Stroma-Dependent Human Acute Myelomonocytic Leukemia Cell Line, NAMO-2, with FLT3 Tandem Duplication

  2006cites this paper
• Identification of Y 589 and Y 599 in the juxtamembrane domain of Flt 3 as ligand-induced autophosphorylation sites involved in binding of Src family kinases and the protein tyrosine phosphatase SHP 2

  2006cites this paper
• Constitutive c-jun N-terminal kinase activity in acute myeloid leukemia derives from Flt3 and affects survival and proliferation.

  2006cites this paper
• Signal Transduction of Oncogenic Flt3

  2005influential citation
• Becker Digital

  year unknowncites this paper